<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39399151</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2057-1577</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Virus evolution</Title><ISOAbbreviation>Virus Evol</ISOAbbreviation></Journal><ArticleTitle>Intrahost evolution leading to distinct lineages in the upper and lower respiratory tracts during SARS-CoV-2 prolonged infection.</ArticleTitle><Pagination><StartPage>veae073</StartPage><MedlinePgn>veae073</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">veae073</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ve/veae073</ELocationID><Abstract><AbstractText>Accumulating evidence points to persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections in immunocompromised individuals as a source of novel lineages. While intrahost evolution of the virus in chronically infected patients has previously been reported, existing knowledge is primarily based on samples from the nasopharynx. In this study, we investigate the intrahost evolution and genetic diversity that accumulated during a prolonged SARS-CoV-2 infection with the Omicron BF.7 sublineage, which is estimated to have persisted for &gt;1 year in an immunosuppressed patient. Based on the sequencing of eight samples collected at six time points, we identified 87 intrahost single-nucleotide variants, 2 indels, and a 362-bp deletion. Our analysis revealed distinct viral genotypes in the nasopharyngeal (NP), endotracheal aspirate, and bronchoalveolar lavage samples. This suggests that NP samples may not offer a comprehensive representation of the overall intrahost viral diversity. Our findings not only demonstrate that the Omicron BF.7 sublineage can further diverge from its already exceptionally mutated state but also highlight that patients chronically infected with SARS-CoV-2 can develop genetically specific viral populations across distinct anatomic compartments. This provides novel insights into the intricate nature of viral diversity and evolution dynamics in persistent infections.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>El Moussaoui</LastName><ForeName>Majdouline</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bontems</LastName><ForeName>Sebastien</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meex</LastName><ForeName>Cecile</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayette</LastName><ForeName>Marie-Pierre</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Department of Microbiology, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lejeune</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Hematology, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Samuel L</ForeName><Initials>SL</Initials><Identifier Source="ORCID">0000-0001-6354-4943</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Laboratory for Clinical and Epidemiological Virology, Rega Institute, KU Leuven, 49 Herestraat, Leuven 3000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dellicour</LastName><ForeName>Simon</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-9558-1052</Identifier><AffiliationInfo><Affiliation>Department of Microbiology, Immunology and Transplantation, Laboratory for Clinical and Epidemiological Virology, Rega Institute, KU Leuven, 49 Herestraat, Leuven 3000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Spatial Epidemiology Lab (SpELL), Université Libre de Bruxelles, 50 Avenue Franklin Roosevelt, Bruxelles 1050, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moutschen</LastName><ForeName>Michel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cambisano</LastName><ForeName>Nadine</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics, GIGA Institute, University of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Renotte</LastName><ForeName>Nathalie</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics, GIGA Institute, University of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bours</LastName><ForeName>Vincent</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics, GIGA Institute, University of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Darcis</LastName><ForeName>Gilles</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-8192-1351</Identifier><AffiliationInfo><Affiliation>Department of Infectious Diseases and General Internal Medicine, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Artesi</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Human Genetics, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics, GIGA Institute, University of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Durkin</LastName><ForeName>Keith</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7475-6618</Identifier><AffiliationInfo><Affiliation>Department of Human Genetics, University Hospital of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Human Genetics, GIGA Institute, University of Liège, 1 Avenue de l'Hôpital, Liège 4000, Belgium.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>31</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virus Evol</MedlineTA><NlmUniqueID>101664675</NlmUniqueID><ISSNLinking>2057-1577</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">ORF8</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">chronic infection</Keyword><Keyword MajorTopicYN="N">genetic compartmentalization</Keyword><Keyword MajorTopicYN="N">immunosuppression</Keyword><Keyword MajorTopicYN="N">intrahost evolution</Keyword><Keyword MajorTopicYN="N">prolonged infection</Keyword><Keyword MajorTopicYN="N">within-host evolution</Keyword></KeywordList><CoiStatement>None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>16</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>14</Day><Hour>7</Hour><Minute>8</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39399151</ArticleId><ArticleId IdType="pmc">PMC11470753</ArticleId><ArticleId IdType="doi">10.1093/ve/veae073</ArticleId><ArticleId IdType="pii">veae073</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Artesi M, Bontems S, Göbbels P. et al. A recurrent mutation at position 26340 of SARS-CoV-2 is associated with failure of the E gene quantitative reverse transcription-PCR utilized in a commercial dual-target diagnostic assay. J Clin Microbiol 2020;58:10–128. doi: 10.1128/JCM.01598-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.01598-20</ArticleId><ArticleId IdType="pmc">PMC7512182</ArticleId><ArticleId IdType="pubmed">32690547</ArticleId></ArticleIdList></Reference><Reference><Citation>Avanzato VA, Matson MJ, Seifert SN. et al. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer. Cell 2020;183:1901–12.e9. doi: 10.1016/j.cell.2020.10.049</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.10.049</ArticleId><ArticleId IdType="pmc">PMC7640888</ArticleId><ArticleId IdType="pubmed">33248470</ArticleId></ArticleIdList></Reference><Reference><Citation>Bloom JD, Neher RA. Fitness effects of mutations to SARS-CoV-2 proteins. Virus Evol 2023;9:vead055. doi: 10.1093/ve/vead055</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vead055</ArticleId><ArticleId IdType="pmc">PMC10506532</ArticleId><ArticleId IdType="pubmed">37727875</ArticleId></ArticleIdList></Reference><Reference><Citation>Bollen N, Artesi M, Durkin K. et al. Exploiting genomic surveillance to map the spatio-temporal dispersal of SARS-CoV-2 spike mutations in Belgium across 2020. Sci Rep 2021;11:18580. doi: 10.1038/s41598-021-97667-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-97667-9</ArticleId><ArticleId IdType="pmc">PMC8448849</ArticleId><ArticleId IdType="pubmed">34535691</ArticleId></ArticleIdList></Reference><Reference><Citation>Bussani R, Zentilin L, Correa R. et al. Persistent SARS-CoV-2 infection in patients seemingly recovered from COVID-19. J Pathol 2023;259:254–63. doi: 10.1002/path.6035</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/path.6035</ArticleId><ArticleId IdType="pmc">PMC10107739</ArticleId><ArticleId IdType="pubmed">36651103</ArticleId></ArticleIdList></Reference><Reference><Citation>Carabelli AM, Peacock TP, Thorne LG. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat Rev Microbiol 2023;21:162–77. doi: 10.1038/s41579-022-00841-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00841-7</ArticleId><ArticleId IdType="pmc">PMC9847462</ArticleId><ArticleId IdType="pubmed">36653446</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaguza C, Hahn AM, Petrone ME. et al. Accelerated SARS-CoV-2 intrahost evolution leading to distinct genotypes during chronic infection. Cell Rep Med 2023;4:100943. doi: 10.1016/j.xcrm.2023.100943</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2023.100943</ArticleId><ArticleId IdType="pmc">PMC9906997</ArticleId><ArticleId IdType="pubmed">36791724</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen D-Y, Chin CV, Kenney D. et al. Spike and nsp6 are key determinants of SARS-CoV-2 Omicron BA.1 attenuation. Nature 2023;615:143–50. doi: 10.1038/s41586-023-05697-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-05697-2</ArticleId><ArticleId IdType="pubmed">36630998</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi B, Choudhary MC, Regan J. et al. Persistence and evolution of SARS-CoV-2 in an immunocompromised host. New Engl J Med 2020;383:2291–93. doi: 10.1056/NEJMc2031364</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2031364</ArticleId><ArticleId IdType="pmc">PMC7673303</ArticleId><ArticleId IdType="pubmed">33176080</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuypers L, Dellicour S, Hong SL. et al. Two years of genomic surveillance in Belgium during the SARS-CoV-2 pandemic to attain country-wide coverage and monitor the introduction and spread of emerging variants. Viruses 2022;14:2301. doi: 10.3390/v14102301</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14102301</ArticleId><ArticleId IdType="pmc">PMC9612291</ArticleId><ArticleId IdType="pubmed">36298856</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadonaite B, Brown J, McMahon TE. et al. Spike deep mutational scanning helps predict success of SARS-CoV-2 clades. Nature 2024;631:617–26. doi: 10.1038/s41586-024-07636-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-024-07636-1</ArticleId><ArticleId IdType="pmc">PMC11254757</ArticleId><ArticleId IdType="pubmed">38961298</ArticleId></ArticleIdList></Reference><Reference><Citation>Dellicour S, Durkin K, Hong SL. et al. A phylodynamic workflow to rapidly gain insights into the dispersal history and dynamics of SARS-CoV-2 lineages. Mol Biol Evol 2021;38:1608–13. doi: 10.1093/molbev/msaa284</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msaa284</ArticleId><ArticleId IdType="pmc">PMC7665608</ArticleId><ArticleId IdType="pubmed">33316043</ArticleId></ArticleIdList></Reference><Reference><Citation>Faria NR, Mellan TA, Whittaker C. et al. Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil. Science 2021;372:815–21. doi: 10.1126/science.abh2644</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abh2644</ArticleId><ArticleId IdType="pmc">PMC8139423</ArticleId><ArticleId IdType="pubmed">33853970</ArticleId></ArticleIdList></Reference><Reference><Citation>Farjo M, Koelle K, Martin MA. et al. Within-host evolutionary dynamics and tissue compartmentalization during acute SARS-CoV-2 infection. J Virol 2024;98:e0161823. doi: 10.1128/jvi.01618-23</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.01618-23</ArticleId><ArticleId IdType="pmc">PMC10805032</ArticleId><ArticleId IdType="pubmed">38174928</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng A, Bevins S, Chandler J. et al. Transmission of SARS-CoV-2 in free-ranging white-tailed deer in the United States. Nat Commun 2023;14:4078. doi: 10.1038/s41467-023-39782-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-023-39782-x</ArticleId><ArticleId IdType="pmc">PMC10333304</ArticleId><ArticleId IdType="pubmed">37429851</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed NE, Vlková M, Faisal MB. et al. Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding. Biol Methods Protoc 2020;5:bpaa014. doi: 10.1093/biomethods/bpaa014</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomethods/bpaa014</ArticleId><ArticleId IdType="pmc">PMC7454405</ArticleId><ArticleId IdType="pubmed">33029559</ArticleId></ArticleIdList></Reference><Reference><Citation>Fung S-Y, Siu K-L, Lin H. et al. SARS-CoV-2 main protease suppresses type I interferon production by preventing nuclear translocation of phosphorylated IRF3. Int J Bio Sci 2021;17:1547–54. doi: 10.7150/ijbs.59943</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.59943</ArticleId><ArticleId IdType="pmc">PMC8071772</ArticleId><ArticleId IdType="pubmed">33907518</ArticleId></ArticleIdList></Reference><Reference><Citation>Gong Y-N, Tsao K-C, Hsiao M-J. et al. SARS-CoV-2 genomic surveillance in Taiwan revealed novel ORF8-deletion mutant and clade possibly associated with infections in Middle East. Emerging Microbes Infect 2020;9:1457–66. doi: 10.1080/22221751.2020.1782271</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1782271</ArticleId><ArticleId IdType="pmc">PMC7473175</ArticleId><ArticleId IdType="pubmed">32543353</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregory DA, Trujillo M, Rushford C. et al. Genetic diversity and evolutionary convergence of cryptic SARS- CoV-2 lineages detected via wastewater sequencing. PLoS Pathogens 2022;18:e1010636. doi: 10.1371/journal.ppat.1010636</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1010636</ArticleId><ArticleId IdType="pmc">PMC9604950</ArticleId><ArticleId IdType="pubmed">36240259</ArticleId></ArticleIdList></Reference><Reference><Citation>Guilbaud R, Franco Yusti A-M, Leducq V. et al. Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study. J Infect Dis 2024;229:1041–49. doi: 10.1093/infdis/jiad499</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiad499</ArticleId><ArticleId IdType="pubmed">37956413</ArticleId></ArticleIdList></Reference><Reference><Citation>Harari S, Miller D, Fleishon S. et al. Using big sequencing data to identify chronic SARS-Coronavirus-2 infections. Nat Commun 2024;15:648. doi: 10.1038/s41467-024-44803-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-44803-4</ArticleId><ArticleId IdType="pmc">PMC10799923</ArticleId><ArticleId IdType="pubmed">38245511</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M, Kishino H, Yano T. Dating of the human-ape splitting by a molecular clock of mitochondrial DNA. J Mol Evol 1985;22:160–74. doi: 10.1007/bf02101694</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf02101694</ArticleId><ArticleId IdType="pubmed">3934395</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill V, Du Plessis L, Peacock TP. et al. The origins and molecular evolution of SARS-CoV-2 lineage B.1.1.7 in the UK. Virus Evol 2022;8:veac080. doi: 10.1093/ve/veac080</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac080</ArticleId><ArticleId IdType="pmc">PMC9752794</ArticleId><ArticleId IdType="pubmed">36533153</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui KPY, Ho JCW, Cheung M-C. et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature 2022;603:715–20. doi: 10.1038/s41586-022-04479-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04479-6</ArticleId><ArticleId IdType="pubmed">35104836</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung C, Kmiec D, Koepke L. et al. Omicron: what makes the latest SARS-CoV-2 variant of concern so concerning? J Virol 2022;96:e0207721. doi: 10.1128/jvi.02077-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/jvi.02077-21</ArticleId><ArticleId IdType="pmc">PMC8941872</ArticleId><ArticleId IdType="pubmed">35225672</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaku Y, Okumura K, Padilla-Blanco M. et al. Virological characteristics of the SARS-CoV-2 JN.1 variant. Lancet Infect Dis 2024;24:e82. doi: 10.1016/S1473-3099(23)00813-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00813-7</ArticleId><ArticleId IdType="pubmed">38184005</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemp SA, Collier DA, Datir RP. et al. SARS-CoV-2 evolution during treatment of chronic infection. Nature 2021;592:277–82. doi: 10.1038/s41586-021-03291-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03291-y</ArticleId><ArticleId IdType="pmc">PMC7610568</ArticleId><ArticleId IdType="pubmed">33545711</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim I-J, Lee Y-H, Khalid MM. et al. SARS-CoV-2 protein ORF8 limits expression levels of Spike antigen and facilitates immune evasion of infected host cells. J Biol Chem 2023;299:104955. doi: 10.1016/j.jbc.2023.104955</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbc.2023.104955</ArticleId><ArticleId IdType="pmc">PMC10289268</ArticleId><ArticleId IdType="pubmed">37354973</ArticleId></ArticleIdList></Reference><Reference><Citation>Machkovech HM, Hahn AM, Garonzik Wang J. et al. Persistent SARS-CoV-2 infection: significance and implications. Lancet Infect Dis 2024;24:e453–62. doi: 10.1016/S1473-3099(23)00815-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(23)00815-0</ArticleId><ArticleId IdType="pubmed">38340735</ArticleId></ArticleIdList></Reference><Reference><Citation>Markov PV, Ghafari M, Beer M. et al. The evolution of SARS-CoV-2. Nat Rev Microbiol 2023;21:361–79. doi: 10.1038/s41579-023-00878-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-023-00878-2</ArticleId><ArticleId IdType="pubmed">37020110</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazur-Panasiuk N, Rabalski L, Gromowski T. et al. Expansion of a SARS-CoV-2 Delta variant with an 872 nt deletion encompassing ORF7a, ORF7b and ORF8, Poland, July to August 2021. Euro Surveillance 2021;26. doi: 10.2807/1560-7917.ES.2021.26.39.2100902</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2021.26.39.2100902</ArticleId><ArticleId IdType="pmc">PMC8485581</ArticleId><ArticleId IdType="pubmed">34596017</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabieva E, Komissarov AB, Klink GV. et al. A highly divergent SARS-CoV-2 lineage B.1.1 sample in a patient with long-term COVID-19. MedRxiv 2023. doi: 10.1101/2023.09.14.23295379</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.09.14.23295379</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermeyer F, Jankowiak M, Barkas N. et al. Analysis of 6.4 million SARS-CoV-2 genomes identifies mutations associated with fitness. Science 2022;376:1327–32. doi: 10.1126/science.abm1208</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abm1208</ArticleId><ArticleId IdType="pmc">PMC9161372</ArticleId><ArticleId IdType="pubmed">35608456</ArticleId></ArticleIdList></Reference><Reference><Citation>Parsons RJ, Acharya P. Evolution of the SARS-CoV-2 Omicron spike. Cell Rep 2023;42:113444. doi: 10.1016/j.celrep.2023.113444</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2023.113444</ArticleId><ArticleId IdType="pmc">PMC10782855</ArticleId><ArticleId IdType="pubmed">37979169</ArticleId></ArticleIdList></Reference><Reference><Citation>Patchett S, Lv Z, Rut W. et al. A molecular sensor determines the ubiquitin substrate specificity of SARS-CoV-2 papain-like protease. Cell Rep 2021;36:109754. doi: 10.1016/j.celrep.2021.109754</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109754</ArticleId><ArticleId IdType="pmc">PMC8423903</ArticleId><ArticleId IdType="pubmed">34547223</ArticleId></ArticleIdList></Reference><Reference><Citation>Pather S, Madhi SA, Cowling BJ. et al. SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines. Front Immunol 2023;14:1130539. doi: 10.3389/fimmu.2023.1130539</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1130539</ArticleId><ArticleId IdType="pmc">PMC10242031</ArticleId><ArticleId IdType="pubmed">37287979</ArticleId></ArticleIdList></Reference><Reference><Citation>Popa A, Genger J-W, Nicholson MD. et al. Genomic epidemiology of superspreading events in Austria reveals mutational dynamics and transmission properties of SARS-CoV-2. Sci Trans Med 2020;12:eabe2555. doi: 10.1126/scitranslmed.abe2555</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe2555</ArticleId><ArticleId IdType="pmc">PMC7857414</ArticleId><ArticleId IdType="pubmed">33229462</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal AD, VanElzakker MB, Aleman S. et al. SARS-CoV-2 reservoir in post-acute sequelae of COVID-19 (PASC). Nat Immunol 2023;24:1616–27. doi: 10.1038/s41590-023-01601-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01601-2</ArticleId><ArticleId IdType="pubmed">37667052</ArticleId></ArticleIdList></Reference><Reference><Citation>Raglow Z, Surie D, Chappell JD. et al. SARS-CoV-2 shedding and evolution in patients who were immunocompromised during the omicron period: a multicentre, prospective analysis. Lancet Microbe 2024;5:e235–46. doi: 10.1016/S2666-5247(23)00336-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00336-1</ArticleId><ArticleId IdType="pubmed">38286131</ArticleId></ArticleIdList></Reference><Reference><Citation>Rambaut A, Drummond AJ, Xie D. et al. Posterior summarization in Bayesian phylogenetics using tracer 1.7. Syst Biol 2018;67:901–04. doi: 10.1093/sysbio/syy032</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/sysbio/syy032</ArticleId><ArticleId IdType="pmc">PMC6101584</ArticleId><ArticleId IdType="pubmed">29718447</ArticleId></ArticleIdList></Reference><Reference><Citation>Roemer C, Sheward DJ, Hisner R. et al. SARS-CoV-2 evolution in the Omicron era. Nat Microbiol 2023;8:1952–59. doi: 10.1038/s41564-023-01504-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41564-023-01504-w</ArticleId><ArticleId IdType="pubmed">37845314</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanderson T, Hisner R, Donovan-Banfield I. et al. A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes. Nature 2023;623:594–600. doi: 10.1038/s41586-023-06649-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-023-06649-6</ArticleId><ArticleId IdType="pmc">PMC10651478</ArticleId><ArticleId IdType="pubmed">37748513</ArticleId></ArticleIdList></Reference><Reference><Citation>Sonnleitner ST, Sonnleitner S, Hinterbichler E. et al. The mutational dynamics of the SARS-CoV-2 virus in serial passages in vitro. Virologica Sin 2022;37:198–207. doi: 10.1016/j.virs.2022.01.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virs.2022.01.029</ArticleId><ArticleId IdType="pmc">PMC8800542</ArticleId><ArticleId IdType="pubmed">35277373</ArticleId></ArticleIdList></Reference><Reference><Citation>Stein SR, Ramelli SC, Grazioli A. et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature 2022;612:758–63. doi: 10.1038/s41586-022-05542-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05542-y</ArticleId><ArticleId IdType="pmc">PMC9749650</ArticleId><ArticleId IdType="pubmed">36517603</ArticleId></ArticleIdList></Reference><Reference><Citation>Su YCF, Anderson DE, Young BE. et al. Discovery and genomic characterization of a 382-nucleotide deletion in ORF7b and ORF8 during the early evolution of SARS-CoV-2. mBio 2020;11:10–128. doi: 10.1128/mBio.01610-20</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.01610-20</ArticleId><ArticleId IdType="pmc">PMC7374062</ArticleId><ArticleId IdType="pubmed">32694143</ArticleId></ArticleIdList></Reference><Reference><Citation>Suchard MA, Lemey P, Baele G. et al. Bayesian phylogenetic and phylodynamic data integration using BEAST 1.10. Virus Evol 2018;4:vey016. doi: 10.1093/ve/vey016</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/vey016</ArticleId><ArticleId IdType="pmc">PMC6007674</ArticleId><ArticleId IdType="pubmed">29942656</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang Z, Yu P, Guo Q. et al. Clinical characteristics and host immunity responses of SARS-CoV-2 Omicron variant BA.2 with deletion of ORF7a, ORF7b and ORF8. Virol J 2023;20:106. doi: 10.1186/s12985-023-02066-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-023-02066-3</ArticleId><ArticleId IdType="pmc">PMC10226014</ArticleId><ArticleId IdType="pubmed">37248496</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorvaldsdóttir H, Robinson JT, Mesirov JP. Integrative Genomics Viewer (IGV): high-performance genomics data visualization and exploration. Briefings Bioinf 2013;14:178–92. doi: 10.1093/bib/bbs017</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bib/bbs017</ArticleId><ArticleId IdType="pmc">PMC3603213</ArticleId><ArticleId IdType="pubmed">22517427</ArticleId></ArticleIdList></Reference><Reference><Citation>Tonkin-Hill G, Martincorena I, Amato R. et al. Patterns of within-host genetic diversity in SARS-CoV-2. eLife 2021;10:e66857. doi: 10.7554/eLife.66857</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.66857</ArticleId><ArticleId IdType="pmc">PMC8363274</ArticleId><ArticleId IdType="pubmed">34387545</ArticleId></ArticleIdList></Reference><Reference><Citation>Turakhia Y, Thornlow B, Hinrichs AS. et al. Ultrafast Sample placement on Existing tRees (UShER) enables real-time phylogenetics for the SARS-CoV-2 pandemic. Nat Genet 2021;53:809–16. doi: 10.1038/s41588-021-00862-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-021-00862-7</ArticleId><ArticleId IdType="pmc">PMC9248294</ArticleId><ArticleId IdType="pubmed">33972780</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Cleemput J, van Snippenberg W, Lambrechts L. et al. Organ-specific genome diversity of replication-competent SARS-CoV-2. Nat Commun 2021;12:6612. doi: 10.1038/s41467-021-26884-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-26884-7</ArticleId><ArticleId IdType="pmc">PMC8595628</ArticleId><ArticleId IdType="pubmed">34785663</ArticleId></ArticleIdList></Reference><Reference><Citation>Van der Moeren N, Selhorst P, Ha M. et al. Viral evolution and immunology of SARS-CoV-2 in a persistent infection after treatment with rituximab. Viruses 2022;14:752. doi: 10.3390/v14040752</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v14040752</ArticleId><ArticleId IdType="pmc">PMC9032773</ArticleId><ArticleId IdType="pubmed">35458482</ArticleId></ArticleIdList></Reference><Reference><Citation>Viana R, Moyo S, Amoako DG. et al. Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa. Nature 2022;603:679–86. doi: 10.1038/s41586-022-04411-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04411-y</ArticleId><ArticleId IdType="pmc">PMC8942855</ArticleId><ArticleId IdType="pubmed">35042229</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner C, Kistler KE, Perchetti GA. et al. Positive selection underlies repeated knockout of ORF8 in SARS-CoV-2 evolution. Nat Commun 2024;15:3207. doi: 10.1038/s41467-024-47599-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-47599-5</ArticleId><ArticleId IdType="pmc">PMC11016114</ArticleId><ArticleId IdType="pubmed">38615031</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkinson SAJ, Richter A, Casey A. et al. Recurrent SARS-CoV-2 mutations in immunodeficient patients. Virus Evol 2022;8:veac050. doi: 10.1093/ve/veac050</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veac050</ArticleId><ArticleId IdType="pmc">PMC9384748</ArticleId><ArticleId IdType="pubmed">35996593</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilm A, Aw PPK, Bertrand D. et al. LoFreq: a sequence-quality aware, ultra-sensitive variant caller for uncovering cell-population heterogeneity from high-throughput sequencing datasets. Nucleic Acids Res 2012;40:11189–201. doi: 10.1093/nar/gks918</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks918</ArticleId><ArticleId IdType="pmc">PMC3526318</ArticleId><ArticleId IdType="pubmed">23066108</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z. Maximum likelihood phylogenetic estimation from DNA sequences with variable rates over sites: approximate methods. J Mol Evol 1994;39:306–14. doi: 10.1007/bf00160154</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/bf00160154</ArticleId><ArticleId IdType="pubmed">7932792</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi H, Wang J, Wang J. et al. The emergence and spread of novel SARS-CoV-2 variants. Front Public Health 2021;9:696664. doi: 10.3389/fpubh.2021.696664</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpubh.2021.696664</ArticleId><ArticleId IdType="pmc">PMC8364952</ArticleId><ArticleId IdType="pubmed">34409009</ArticleId></ArticleIdList></Reference><Reference><Citation>Young BE, Fong S-W, Chan Y-H. et al. Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study. Lancet 2020;396:603–11. doi: 10.1016/S0140-6736(20)31757-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)31757-8</ArticleId><ArticleId IdType="pmc">PMC7434477</ArticleId><ArticleId IdType="pubmed">32822564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Z, Li S, Su J. et al. Symphonizing pileup and full-alignment for deep learning-based long-read variant calling. Nat Comput Sci 2022;2:797–803. doi: 10.1038/s43588-022-00387-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43588-022-00387-x</ArticleId><ArticleId IdType="pubmed">38177392</ArticleId></ArticleIdList></Reference><Reference><Citation>Zinzula L. Lost in deletion: the enigmatic ORF8 protein of SARS-CoV-2. Biochem Biophys Res Commun 2021;538:116–24. doi: 10.1016/j.bbrc.2020.10.045</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.10.045</ArticleId><ArticleId IdType="pmc">PMC7577707</ArticleId><ArticleId IdType="pubmed">33685621</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>